SCHEMBL312167

SCHEMBL312167

CCOC(=O)Nc1cc(O)ccc1-c1cc(=O)c2ccc(O)c(O)c2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
AKR1B1 P15121 1/20 0.37
HSD17B10 Q99714 4/20 0.36
HPGD P15428 4/20 0.36
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
ALDH1A1 P00352 4/20 0.36
ALOX15 P16050 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311236 0.88 PLA2G7 (0.45) CYP1A2CYP2C9CYP2C19HSD17B10HPGD
SCHEMBL312228 0.86 CYP1A2 (0.37) CYP1A2CYP2C9CYP2C19SMN1; SMN2AKR1B1
SCHEMBL311889 0.85 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19SMN1; SMN2HSD17B10
SCHEMBL312241 0.85 ALDH1A1 (0.43) CYP1A2CYP2C9CYP2C19SMN1; SMN2AKR1B1
SCHEMBL311496 0.84 HPGD (0.41) CYP1A2CYP2C9CYP2C19SMN1; SMN2HSD17B10
SCHEMBL311043 0.84 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19SMN1; SMN2HSD17B10
SCHEMBL312303 0.83 TUBB4A (0.40) CYP1A2CYP2C9CYP2C19SMN1; SMN2HSD17B10
SCHEMBL311883 0.83 GAA (0.46) CYP1A2CYP2C9CYP2C19SMN1; SMN2HSD17B10
SCHEMBL10215441 0.81 KDM4E (0.45) SMN1; SMN2HSD17B10HPGDKDM4EMEN1
SCHEMBL311994 0.81 KMT2A (0.46) CYP1A2CYP2C9CYP2C19SMN1; SMN2AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed